The AugmentSM Treatment


Screen Shot 2017-08-04 at 11.24.18 AM


What is the Augment Treatment?

Egg health is a key factor in fertility. While there are many factors that contribute to egg health, having adequate levels of energy inside of the egg is essential for fertilization and embryo development.¹

The Augment treatment uses the energy-producing mitochondria from a patient’s own EggPC cells-immaculate egg cells found in the protective lining of her ovaries-to supplement the existing mitochondria in her eggs. This process is designed to improve the health of a patient’s existing eggs, and enhance the IVF procedure. The Augment treatment has resulted in positive patient outcomes.²

Why would a patient need the Augment Treatment?

Your body is able to function thanks to hard-working mitochondria, which create the energy for your cells. The Augment treatment is based on multiple published reports that show adding mitochondria to an egg from a mitochondria-rich source, such as a donor egg, aids in embryo development.³

For the Augment treatment, we use energy-producing mitochondria from your own egg precursor (EggPC) cells to revitalize your eggs.

What can I expect from the Augment Treatment?

  • After your fertility doctor provides a small sample from the outer cortex of your ovary, the Augment treatment begins when the sample gets to a lab.
  • The tissue is processed to isolate mitochondria, the cell’s energy producers, from your EggPC cells.
  • Your fertility specialist combines the energy-producing mitochondria with the sperm, which are then added to your egg. The energy-producing mitochondria from your EggPC cells supplement your egg’s existing mitochondria during IVF.

The Augment Treatment Process



For more information visit Augment Treatment



  1. S. Chappel. The Role of Mitochondria from Mature Oocyte to Viable Blastocyst. Obstetrics and Gynecology International. 2013:10. doi:101155/2013/183024
  2. OvaScience<sup>SM</sup> data on file.
  3. Studies published in peer-reviewed medical journals, including Molecular Human Reproduction (1998), Human Cell (2004), Electronic Journal of Biology (2005), Reproduction Research (2006), Human Reproduction (2001) and Reproductive Biomedicine (2011), involved a number of species, including humans, in which third-party scientists demonstrated that the addition of mitochondria to eggs increased cellular energy levels, egg quality and the likelihood of fertilization and healthy live births.